NEW YORK (GenomeWeb) – Courtagen Life Sciences said today that it has partnered with Sciencewerke for the international distribution of its clinical next-generation sequencing tests.

Sciencewerke is a sales, marketing, and distribution company. It is headquartered in Singapore and has offices in Malaysia and Indonesia. It will distribute Courtagen's NGS-based tests for neurological and metabolic disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.